Healthcare
Innovative Midfoot Solutions
October 22, 2026
More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution
More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution
abioSCOPE® is point-of-care platform that measures a biomarker that may begin rising 48 to 72 hours before a clinical diagnosis for sepsis
OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.
A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease
A breakfast networking event in an informal setting to foster connections and cultivate mutually beneficial relationships